AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 20863554 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin 50 mg/m² + Doxorubicin 45 mg/m² + G‐CSF 5 μg/kg + Paclitaxel 160 mg/m² (CDP)
Number of subjects: 552
Study 18508824 — intervention group
Group type: EXPERIMENTAL
Intervention: Cell phone-based exercise programme (daily endurance walking at 80% of maximal capacity, adjusted monthly based on ISWT results)
Number of subjects: 48
Study 18508824 — intervention group
Group type: EXPERIMENTAL
Intervention: Cell phone-based exercise programme
Number of subjects: 48
Study 18508824 — intervention group
Group type: COMPARATOR
Intervention: Control group (verbal instructions for daily walking exercise at home)
Number of subjects: 48
Study 17265571 — intervention group
Group type: EXPERIMENTAL
Intervention: etoricoxib (≥ 60 mg/day)
Number of subjects: 6500
Study 17265571 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 6500
Study 17265571 — intervention group
Group type: COMPARATOR
Intervention: non-naproxen traditional NSAIDs (ibuprofen and diclofenac)
Number of subjects: 6500
Study 17265571 — intervention group
Group type: COMPARATOR
Intervention: naproxen (1000 mg/day)
Number of subjects: 6500
Study 14635505 — intervention group
Group type: EXPERIMENTAL
Intervention: Furosemide (40 mg)
Number of subjects: 9
Study 14635505 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetazolamide (500 mg)
Number of subjects: 9
Study 14635505 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 9
Study 10868999 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisone for two months
Number of subjects: 868
Study 10868999 — intervention group
Group type: COMPARATOR
Intervention: Prednisone for three months or more
Number of subjects: 868
Study 10868999 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisone for longer durations (up to seven months)
Number of subjects: 868
Study 9063785 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral ketamine
Number of subjects: 19
Study 9063785 — intervention group
Group type: COMPARATOR
Intervention: 300 mg acetaminophen with codeine phosphate and diphenhydramine
Number of subjects: 19
Study 8240534 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.75% metronidazole gel
Number of subjects: 51
Study 8240534 — intervention group
Group type: COMPARATOR
Intervention: Excipient (placebo)
Number of subjects: 51
Study 2425961 — intervention group
Group type: EXPERIMENTAL
Intervention: S-Adenosyl methionine (SAM)
Number of subjects: 0
Study 2425961 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31955013 — intervention group
Group type: EXPERIMENTAL
Intervention: Ad libitum TRF
Number of subjects: 23
Study 31955013 — intervention group
Group type: COMPARATOR
Intervention: Isocaloric TRF
Number of subjects: 23
Study 30716452 — intervention group
Group type: EXPERIMENTAL
Intervention: Fiber posts (Subgroup A)
Number of subjects: 60
Study 30716452 — intervention group
Group type: COMPARATOR
Intervention: No fiber posts (Subgroup B)
Number of subjects: 60
Study 30716452 — intervention group
Group type: EXPERIMENTAL
Intervention: Fiber posts in molars (Group 2A)
Number of subjects: 60
Study 30716452 — intervention group
Group type: EXPERIMENTAL
Intervention: Tooth type (premolars vs molars)
Number of subjects: 60
Study 30716452 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of post
Number of subjects: 60
Study 28852276 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-led intervention
Number of subjects: 824
Study 28852276 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 824
Study 25479584 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus 10 mg/d
Number of subjects: 410
Study 25479584 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 410
Study 23265352 — intervention group
Group type: EXPERIMENTAL
Intervention: L-DOPS co-administered with entacapone
Number of subjects: 16
Study 23265352 — intervention group
Group type: COMPARATOR
Intervention: Entacapone alone
Number of subjects: 16
Study 23265352 — intervention group
Group type: COMPARATOR
Intervention: L-DOPS alone
Number of subjects: 16
Study 21303529 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive spinal manipulative therapy (SMT) - 1 monthly session for 10 months
Number of subjects: 98
Study 21303529 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive spinal manipulative therapy with home exercise program (SMT + exercise) - 1 monthly SMT session combined with home exercises for 10 months
Number of subjects: 98
Study 21303529 — intervention group
Group type: COMPARATOR
Intervention: Attention-control group - meeting with a chiropractor every two months for 10 months
Number of subjects: 98
Study 21303529 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (SMT, SMT + exercise, attention-control)
Number of subjects: 98
Study 21303529 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive phase of the trial
Number of subjects: 98
Study 19673707 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen (1000 mg)
Number of subjects: 25
Study 19673707 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen (800 mg)
Number of subjects: 25
Study 19673707 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen/Hydrocodone (650 mg acetaminophen with 10 mg hydrocodone)
Number of subjects: 25
Study 19673707 — intervention group
Group type: COMPARATOR
Intervention: Placebo (800 mg of lactose)
Number of subjects: 25
Study 16430622 — intervention group
Group type: EXPERIMENTAL
Intervention: Bicalutamide 150 mg once daily
Number of subjects: 8113
Study 16430622 — intervention group
Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 8113
Study 15008832 — intervention group
Group type: EXPERIMENTAL
Intervention: Euglycaemia with alcohol
Number of subjects: 17
Study 15008832 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoglycaemia with alcohol
Number of subjects: 17
Study 15008832 — intervention group
Group type: COMPARATOR
Intervention: Hypoglycaemia without alcohol
Number of subjects: 17
Study 15008832 — intervention group
Group type: COMPARATOR
Intervention: Euglycaemia with placebo
Number of subjects: 17
Study 15008832 — intervention group
Group type: COMPARATOR
Intervention: Hypoglycaemia with placebo
Number of subjects: 17
Study 11482747 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolterodine 2 mg twice daily for up to 12 months
Number of subjects: 714
Study 9444018 — intervention group
Group type: EXPERIMENTAL
Intervention: Praziquantel 5 mg/kg
Number of subjects: 109
Study 9444018 — intervention group
Group type: EXPERIMENTAL
Intervention: Praziquantel 2.5 mg/kg
Number of subjects: 109
Study 9444018 — intervention group
Group type: EXPERIMENTAL
Intervention: Mebendazole 800 mg in 10d table salt
Number of subjects: 109
Study 9444018 — intervention group
Group type: EXPERIMENTAL
Intervention: Mebendazole 400 mg in 10d table salt
Number of subjects: 109
Study 7962320 — intervention group
Group type: EXPERIMENTAL
Intervention: Lo/Ovral
Number of subjects: 0
Study 7962320 — intervention group
Group type: EXPERIMENTAL
Intervention: Ovral
Number of subjects: 0
Study 7962320 — intervention group
Group type: COMPARATOR
Intervention: Control (never used OCs or discontinued for at least 24 months)
Number of subjects: 0
Study 3454918 — intervention group
Group type: EXPERIMENTAL
Intervention: Oscillation frequencies of 1, 2, 3, 5, 8, 13 and 20 Hz
Number of subjects: 30
Study 3454918 — intervention group
Group type: EXPERIMENTAL
Intervention: Age groups (20-23, 40-55, 60-80)
Number of subjects: 30
Study 29199013 — intervention group
Group type: EXPERIMENTAL
Intervention: Netarsudil 0.02% once daily (q.d.)
Number of subjects: 1167
Study 29199013 — intervention group
Group type: EXPERIMENTAL
Intervention: Netarsudil 0.02% twice daily (b.i.d.)
Number of subjects: 1167
Study 29199013 — intervention group
Group type: COMPARATOR
Intervention: Timolol 0.5% twice a day (b.i.d.)
Number of subjects: 1167
Study 27397838 — intervention group
Group type: EXPERIMENTAL
Intervention: Evidence-based practice education (4-hour live sessions + web-based module + mentoring)
Number of subjects: 85
Study 27397838 — intervention group
Group type: COMPARATOR
Intervention: Research utilization education (4-hour live sessions)
Number of subjects: 85
Study 24342252 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternate dosing schedule (0, 2, 12 months)
Number of subjects: 220
Study 24342252 — intervention group
Group type: COMPARATOR
Intervention: Standard dosing schedule (0, 2, 6 months)
Number of subjects: 220
Study 22844002 — intervention group
Group type: EXPERIMENTAL
Intervention: High-risk human papillomavirus (hrHPV) testing combined with cervical cytology
Number of subjects: 598
Study 22844002 — intervention group
Group type: COMPARATOR
Intervention: Control group (hrHPV-negative women)
Number of subjects: 598
Study 22844002 — intervention group
Group type: COMPARATOR
Intervention: hrHPV-negative women with normal or ASCUS cytological findings
Number of subjects: 598
Study 22844002 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall population
Number of subjects: 598
Study 22844002 — intervention group
Group type: EXPERIMENTAL
Intervention: If hrHPV-negative women had not been referred to colposcopy
Number of subjects: 598
Study 20357149 — intervention group
Group type: EXPERIMENTAL
Intervention: Airway Scope (AWS)
Number of subjects: 24
Study 20357149 — intervention group
Group type: EXPERIMENTAL
Intervention: Airtraq (ATQ)
Number of subjects: 24
Study 20357149 — intervention group
Group type: COMPARATOR
Intervention: Macintosh laryngoscope (ML)
Number of subjects: 24
Study 18315966 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous treatment of displaced intra-articular calcaneal fractures
Number of subjects: 21
Study 18315966 — intervention group
Group type: COMPARATOR
Intervention: Control foot (contralateral foot)
Number of subjects: 21
Study 18315966 — intervention group
Group type: EXPERIMENTAL
Intervention: Heel time ratio
Number of subjects: 21
Study 15951651 — intervention group
Group type: EXPERIMENTAL
Intervention: Local corticosteroid injection
Number of subjects: 164
Study 15951651 — intervention group
Group type: COMPARATOR
Intervention: Naproxen
Number of subjects: 164
Study 15951651 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 164
Study 14634366 — intervention group
Group type: EXPERIMENTAL
Intervention: Portable device providing extrinsic auditory feedback in gait therapy
Number of subjects: 16
Study 14634366 — intervention group
Group type: COMPARATOR
Intervention: Conventional gait therapy only
Number of subjects: 16
Study 10450289 — intervention group
Group type: EXPERIMENTAL
Intervention: DASH dietary pattern
Number of subjects: 0
Study 10450289 — intervention group
Group type: COMPARATOR
Intervention: Other dietary patterns
Number of subjects: 0
Study 8678934 — intervention group
Group type: EXPERIMENTAL
Intervention: Theophylline
Number of subjects: 15
Study 8678934 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 1746296 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet and exercise followed by gemfibrozil therapy
Number of subjects: 3328
Study 6280794 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose cyclophosphamide alone
Number of subjects: 0
Study 6280794 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide plus methotrexate
Number of subjects: 0
Study 6280794 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide plus methotrexate plus vincristine
Number of subjects: 0
Study 6280794 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide plus high‐dose methotrexate plus vincristine
Number of subjects: 0
Study 6280794 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic brain radiotherapy
Number of subjects: 0
Study 6280794 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintenance chemotherapy
Number of subjects: 0
Study 6280794 — intervention group
Group type: EXPERIMENTAL
Intervention: MACC (methotrexate, adriamycin, cyclophosphamide, CCNU)
Number of subjects: 0
Study 6280794 — intervention group
Group type: EXPERIMENTAL
Intervention: CCV/AV (cyclophosphamide, CCNU, vincristine, alternating with adriamycin and vincristine)
Number of subjects: 0
Study 6280794 — intervention group
Group type: EXPERIMENTAL
Intervention: Split course radiotherapy (total 45 Gy over 4 weeks)
Number of subjects: 0
Study 6280794 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic brain irradiation
Number of subjects: 0
Study 6280794 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy to the chest
Number of subjects: 0
Study 6280794 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall treatment
Number of subjects: 0
Study 30724405 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Rehabilitation (CR)
Number of subjects: 475
Study 30724405 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 475
Study 29177407 — intervention group
Group type: EXPERIMENTAL
Intervention: Extra early standard dose of measles vaccine (MV) (Edmonston‐Zagreb strain)
Number of subjects: 8309
Study 29177407 — intervention group
Group type: COMPARATOR
Intervention: Control group (no extra MV)
Number of subjects: 8309
Study 26586780 — intervention group
Group type: EXPERIMENTAL
Intervention: Continued thienopyridine
Number of subjects: 11648
Study 26586780 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11648
Study 23644703 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 254
Study 23644703 — intervention group
Group type: COMPARATOR
Intervention: Placebo (5% aqueous dextrose solution)
Number of subjects: 254
Study 22529160 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured home-based program (S-pre, n = 31)
Number of subjects: 60
Study 22529160 — intervention group
Group type: EXPERIMENTAL
Intervention: Unstructured home-based program (U-free, n = 14)
Number of subjects: 60
Study 22529160 — intervention group
Group type: COMPARATOR
Intervention: Healthy participants (n = 15)
Number of subjects: 60
Study 20176670 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephonic interpretation
Number of subjects: 1201
Study 20176670 — intervention group
Group type: EXPERIMENTAL
Intervention: In-person interpretation
Number of subjects: 1201
Study 20176670 — intervention group
Group type: COMPARATOR
Intervention: Bilingual physician
Number of subjects: 1201
Study 17377800 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl iontophoretic transdermal system (ITS)
Number of subjects: 275
Study 17377800 — intervention group
Group type: COMPARATOR
Intervention: Morphine intravenous patient‐controlled analgesia (IV PCA)
Number of subjects: 275
Study 15705921 — intervention group
Group type: COMPARATOR
Intervention: LT4 monotherapy (n = 48)
Number of subjects: 141
Study 15705921 — intervention group
Group type: EXPERIMENTAL
Intervention: LT4/LT3, ratio 10:1 (n = 46)
Number of subjects: 141
Study 15705921 — intervention group
Group type: EXPERIMENTAL
Intervention: LT4/LT3, ratio 5:1 (n = 47)
Number of subjects: 141
Study 12730320 — intervention group
Group type: EXPERIMENTAL
Intervention: Model predicting 12-month mortality based on age, gender, ADL difficulty, medical conditions, prior year hospitalizations, and primary caregiver relationship
Number of subjects: 3858
Study 12730320 — intervention group
Group type: EXPERIMENTAL
Intervention: Model predicting mortality based on two or more activities of daily living (ADLs) difficulty
Number of subjects: 3858
Study 12730320 — intervention group
Group type: EXPERIMENTAL
Intervention: Validation test of the prediction model
Number of subjects: 3858
Study 12198786 — intervention group
Group type: EXPERIMENTAL
Intervention: Memory for responses to the softest and loudest stimuli
Number of subjects: 0
Study 12198786 — intervention group
Group type: EXPERIMENTAL
Intervention: Memory for responses to intermediate stimulus amplitudes
Number of subjects: 0
Study 12198786 — intervention group
Group type: EXPERIMENTAL
Intervention: Memory for the range of stimulus amplitudes
Number of subjects: 0
Study 8748357 — intervention group
Group type: EXPERIMENTAL
Intervention: Tube feeding (TF)
Number of subjects: 50
Study 8748357 — intervention group
Group type: COMPARATOR
Intervention: Control (maintenance i.v. fluid)
Number of subjects: 50
Study 8748357 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 50
Study 1940094 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine (25 mg/daily)
Number of subjects: 61
Study 1940094 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study 6117576 — intervention group
Group type: EXPERIMENTAL
Intervention: Nabilone (4 or 5 mg)
Number of subjects: 8
Study 6117576 — intervention group
Group type: EXPERIMENTAL
Intervention: Nabilone (1 or 2 mg)
Number of subjects: 8
Study 6117576 — intervention group
Group type: EXPERIMENTAL
Intervention: Nabilone (lower doses)
Number of subjects: 8
Study 6117576 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 31138184 — intervention group
Group type: EXPERIMENTAL
Intervention: Norethindrone 5 mg three times daily
Number of subjects: 50
Study 31138184 — intervention group
Group type: COMPARATOR
Intervention: Combined oral contraceptives (OCP)
Number of subjects: 50
Study 31138184 — intervention group
Group type: EXPERIMENTAL
Intervention: Norethindrone
Number of subjects: 50
Study 27743908 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent-based cognitive behavioral therapy
Number of subjects: 52
Study 27743908 — intervention group
Group type: COMPARATOR
Intervention: Parent-based psychoeducation
Number of subjects: 52
Study 25635606 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined group (plyometric + acceleration + dribbling + shooting)
Number of subjects: 26
Study 25635606 — intervention group
Group type: COMPARATOR
Intervention: Control group (soccer training only)
Number of subjects: 26
Study 25012423 — intervention group
Group type: EXPERIMENTAL
Intervention: Group support psychotherapeutic intervention
Number of subjects: 77
Study 25012423 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 77
Study 21136310 — intervention group
Group type: EXPERIMENTAL
Intervention: Postconditioning
Number of subjects: 43
Study 21136310 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (Control)
Number of subjects: 43
Study 19349122 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid cognitive-behavioral therapy (H-CBT)
Number of subjects: 0
Study 19349122 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 17967760 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet 3 (40% carbohydrate, 30% fat, 25% protein)
Number of subjects: 94
Study 17967760 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet 4 (40% carbohydrate, 30% fat, 25% protein and caloric restriction)
Number of subjects: 94
Study 17967760 — intervention group
Group type: COMPARATOR
Intervention: Diet 1 (55% carbohydrate, 30% fat, 15% protein)
Number of subjects: 94
Study 17967760 — intervention group
Group type: COMPARATOR
Intervention: Diet 2 (55% carbohydrate, 30% fat, 15% protein and caloric restriction)
Number of subjects: 94
Study 15534251 — intervention group
Group type: EXPERIMENTAL
Intervention: Creatine supplementation (5 g per day)
Number of subjects: 104
Study 15649161 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser acupuncture on P6 point and saline infusion
Number of subjects: 120
Study 15649161 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoclopramide 0.1 mg.kg(‐1) i.v. and sham laser
Number of subjects: 120
Study 15649161 — intervention group
Group type: COMPARATOR
Intervention: Sham laser and saline infusion
Number of subjects: 120
Study 10578981 — intervention group
Group type: EXPERIMENTAL
Intervention: Sialosyl-Tn (STn) monoclonal antibody staining
Number of subjects: 72
Study 9081852 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.25 mg ramipril daily
Number of subjects: 619
Study 9081852 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 619
Study 1847026 — intervention group
Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (15,000 UaXa, subcutaneous, daily for 6 months)
Number of subjects: 44
Study 1847026 — intervention group
Group type: COMPARATOR
Intervention: Placebo (subcutaneous, daily for 6 months)
Number of subjects: 44
Study 6340974 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimethoprim (250 mg)/sulfamethopyrazine (200 mg) combination given once daily after a double loading dose on the first day.
Number of subjects: 68
Study 6340974 — intervention group
Group type: COMPARATOR
Intervention: Ampicillin 500 mg 4-times daily.
Number of subjects: 68
Study 31655882 — intervention group
Group type: EXPERIMENTAL
Intervention: Glove-finger pack soaked with saline solution
Number of subjects: 120
Study 31655882 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine-soaked pack
Number of subjects: 120
Study 30667512 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard radial extracorporeal shock wave device
Number of subjects: 135
Study 30667512 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard radial extracorporeal shock wave device modified to give a more sophisticated appearance
Number of subjects: 135
Study 30667512 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard radial extracorporeal shock wave device modified to give a more austere appearance
Number of subjects: 135
Study 27377131 — intervention group
Group type: EXPERIMENTAL
Intervention: iPad applications targeting VMI skills
Number of subjects: 20
Study 27377131 — intervention group
Group type: COMPARATOR
Intervention: Traditional occupational therapy intervention sessions targeting VMI skills
Number of subjects: 20
Study 26290524 — intervention group
Group type: EXPERIMENTAL
Intervention: In-home caregiver-mediated module
Number of subjects: 147
Study 26290524 — intervention group
Group type: COMPARATOR
Intervention: Group-based caregiver education module
Number of subjects: 147
Study 24830400 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic clip
Number of subjects: 195
Study 24830400 — intervention group
Group type: COMPARATOR
Intervention: Endoloop
Number of subjects: 195
Study 22811376 — intervention group
Group type: EXPERIMENTAL
Intervention: MVit (VitC: 200 mg; VitE: 400 IU; VitB6: 25 mg; Folic Acid: 400 ug; VitB12: 400 ug)
Number of subjects: 100
Study 22811376 — intervention group
Group type: EXPERIMENTAL
Intervention: MVit + N3 (2 g N3, 760 mg EPA, 440 mg DHA)
Number of subjects: 100
Study 22811376 — intervention group
Group type: EXPERIMENTAL
Intervention: MVit
Number of subjects: 100
Study 22811376 — intervention group
Group type: EXPERIMENTAL
Intervention: MVit + N3
Number of subjects: 100
Study 22811376 — intervention group
Group type: EXPERIMENTAL
Intervention: N3 (2 g N3, 760 mg EPA, 440 mg DHA)
Number of subjects: 100
Study 19056661 — intervention group
Group type: EXPERIMENTAL
Intervention: Garlic supplementation (aged garlic and steam-distilled garlic oil) for 7.3 years
Number of subjects: 3411